Webinar Series 2026
Webinar videorecordings will be permanently accessible via EFOMP's elearning platform e-LEMENT.
EFOMP Special Interest Group on Radionuclide Internal Dosimetry (SIGFRID) webinar series
About SIGFRID
The objective of the Special Interest Group for Radionuclide Internal Dosimetry (SIG_FRID) is to establish a network of medical physicists working in radionuclide dosimetry. The SIG aims to fulfil the need for networking, education, research and professional exchanges in this field. The SIG_FRID was created in February 2021 and has a membership of 277 Medical Physicists (December 2025) specialised in this subfield.
The rationale of this SIG
Therapeutic applications in nuclear medicine are developing rapidly. They use a growing range of vectors (simple vector molecules, peptides, antibodies), medical devices (radiolabelled microspheres) and radioactive isotopes (beta, but also alpha or Auger). Due to this variety, the characterisation of the irradiation delivered to the patient is at the same time stimulating and challenging. Nevertheless, treatment planning and verification in nuclear medicine therapy, seldom performed in the past in radioiodine therapy for benign or malignant thyroid disease, is nowadays requested (implementation in national law of the Basic Safety Standard Council Directive EU 2013/59). Moreover, reliable absorbed dose calculations are now available thanks to technological and scientific developments of the last decades. More information about SIGFRID could be found via this link.
SIGFRID is oranising scientific meetings and case reports. A scientific meeting usually includes 3 x 30 min talks, followed by a general discussion (30 min) and a case report 30 min talk, followed by a general discussion (30 min).
Educational courses will complement the scientific meetings and case reports in 2026 - 2027. This initiative will cater profesionnals and students seeking to learn and expand their expertise in nuclear medicine dosimetry.
Case reports are open to all, but Scientific meetings are restricted to SIG_FRID members.
Organisers: SIGFRID
Steffie Peters & Silvano Gnesin
Email: webinars@efomp.org
|
|
SIGFRID webinar |
Topic |
Lecturers-Panelists |
|---|---|---|---|
| 1 |
February 24, 2026 3:00 PM - 5:00 PM CEST |
EFOMP SIGFRID Scientific Meeting. Registration is OPEN! |
TBA |
| 2 |
April 21, 2026 12:00 PM - 1:00 PM CEST |
EFOMP SIGFRID Dosimetry Case Report Meeting. Registration is OPEN! |
TBA |
| 3 |
June 16, 2026 3:00 PM - 5:00 PM CEST |
EFOMP SIGFRID Scientific Meeting. Registration is OPEN! |
TBA |
| 4 |
August 11, 2026 12:00 PM - 1:00 PM CEST |
EFOMP SIGFRID Dosimetry Case Report Meeting. Registration is OPEN! |
TBA |
| 5 |
October 6, 2026 3:00 PM - 5:00 PM CEST |
EFOMP SIGFRID Scientific Meeting. Registration is OPEN! |
TBA |
| 6 |
December 8, 2026 12:00 PM - 1:00 PM CEST |
EFOMP SIGFRID Dosimetry Case Report Meeting. Registration is OPEN! |
TBA |
EFOMP European & International Matters Committee webinar series
About European & International Matters Committee
About Early Career Special Interest Group
The European & international Matters Committee is responsible to the Council of the Federation for the representation of the interest of the Federation to the various bodies across the European Union and beyond.
This year, the committee will organise a series of webinars together with the EFOMP Special Interest Group on Early Careers.
Organisers:
Antonio López Medina, Antonio Jreije, Irene Polycarpou & Leticia Irazola Rosales
Email: webinars@efomp.org
|
|
EUM webinar |
Topic |
Lecturers-Panelists |
|---|---|---|---|
| 1 |
January 29, 2026 4:00 PM - 5:00 PM CET
|
EFOMP-AAPM webinar on "Perspectives of Medical Physics Research in Academia, Industry and Government" Registration is OPEN! |
Richard Amos, PhD, Associate Professor and Lead for Translational Proton Therapy Physics, Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom Michel Moreau, PhD, Research Scientist, Elekta, Atlanta, United States James Renaud, PhD, Research Officer, Metrology, National Research Council Canada, Ottawa, Ontario, Canada |